137 related articles for article (PubMed ID: 11112220)
1. Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics.
Baehner R; Magrane G; Balassanian R; Chang C; Millward C; Wakil AE; Osorio RW; Waldman FM
Hum Pathol; 2000 Nov; 31(11):1425-9. PubMed ID: 11112220
[TBL] [Abstract][Full Text] [Related]
2. Organ recipients suffering from undifferentiated neuroendocrine small-cell carcinoma of donor origin: a case report.
Foltys D; Linkermann A; Heumann A; Hoppe-Lotichius M; Heise M; Schad A; Schneider J; Bender K; Schmid M; Mauer D; Peixoto N; Otto G
Transplant Proc; 2009; 41(6):2639-42. PubMed ID: 19715991
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite analysis in post-transplantation lymphoproliferative disorder to determine donor/recipient origin.
Ng IO; Shek TW; Thung SN; Ye MM; Lo CM; Fan ST; Lee JM; Chan KW; Cheung AN
Mod Pathol; 2000 Nov; 13(11):1180-5. PubMed ID: 11106074
[TBL] [Abstract][Full Text] [Related]
4. Donor origin of posttransplant lymphoproliferative disorder localized to a liver allograft: demonstration by fluorescence in situ hybridization.
Lones MA; Lopez-Terrada D; Weiss LM; Shintaku IP; Said JW
Arch Pathol Lab Med; 1997 Jul; 121(7):701-6. PubMed ID: 9240905
[TBL] [Abstract][Full Text] [Related]
5. Retransplantation for donor-derived neuroendocrine tumor.
Begum R; Harnois D; Satyanarayana R; Krishna M; Halling KC; Kim GP; Nguyen JH; Keaveny AP
Liver Transpl; 2011 Jan; 17(1):83-7. PubMed ID: 21254348
[TBL] [Abstract][Full Text] [Related]
6. Skin carcinoma arising from donor cells in a kidney transplant recipient.
Aractingi S; Kanitakis J; Euvrard S; Le Danff C; Peguillet I; Khosrotehrani K; Lantz O; Carosella ED
Cancer Res; 2005 Mar; 65(5):1755-60. PubMed ID: 15753371
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
[TBL] [Abstract][Full Text] [Related]
8. Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review.
Kim JK; Carmody IC; Cohen AJ; Loss GE
Clin Transplant; 2009; 23(4):571-4. PubMed ID: 19681978
[TBL] [Abstract][Full Text] [Related]
9. Identification of donor melanoma in a renal transplant recipient.
Wilson LJ; Horvat RT; Tilzer L; Meis AM; Montag L; Huntrakoon M
Diagn Mol Pathol; 1992 Dec; 1(4):266-71. PubMed ID: 1364174
[TBL] [Abstract][Full Text] [Related]
10. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
[TBL] [Abstract][Full Text] [Related]
11. De novo concurrent papillary renal cell carcinoma and angiomyolipoma in a kidney allograft: evidence of donor origin.
Rotman S; Déruaz C; Venetz JP; Chaubert P; Benhattar J; Meuwly JY; Jichlinski P; Guillou L; Moll S; Pascual M; Lemoine R
Hum Pathol; 2006 Apr; 37(4):481-7. PubMed ID: 16564925
[TBL] [Abstract][Full Text] [Related]
12. Primary renal cell carcinoma in a transplanted kidney: genetic evidence of recipient origin.
Boix R; Sanz C; Mora M; Quer A; Beyer K; Musulen E; González C; Bayona S; Saladié JM; Ariza A
Transplantation; 2009 Apr; 87(7):1057-61. PubMed ID: 19352128
[TBL] [Abstract][Full Text] [Related]
13. Tumor origin and CD20 expression in posttransplant lymphoproliferative disorder occurring in solid organ transplant recipients: implications for immune-based therapy.
Gulley ML; Swinnen LJ; Plaisance KT; Schnell C; Grogan TM; Schneider BG;
Transplantation; 2003 Sep; 76(6):959-64. PubMed ID: 14508361
[TBL] [Abstract][Full Text] [Related]
14. Remission of transplanted melanoma--clinical course and tumour cell characterisation.
Elder GJ; Hersey P; Branley P
Clin Transplant; 1997 Dec; 11(6):565-8. PubMed ID: 9408685
[TBL] [Abstract][Full Text] [Related]
15. Delayed recurrence of hepatocellular carcinoma after liver transplantation: detection of origin by chromosomal analysis.
Al-Joundi T; Gibson S; Brunt EM; Shakil O; Lee RS; Di Bisceglie AM
Liver Transpl; 2000 May; 6(3):374-5. PubMed ID: 10827244
[TBL] [Abstract][Full Text] [Related]
16. Donor-Derived Neuroendocrine Carcinoma Transmission to Two Kidney Transplant Recipients Demonstrated by Short Tandem Repeat Analysis: A Case Report.
Takeda K; Mittenzwei R; Geisinger KR; Datto MB; Rebellato LM
Transplant Proc; 2021 May; 53(4):1337-1341. PubMed ID: 33824012
[TBL] [Abstract][Full Text] [Related]
17. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area.
Cuellar-Rodriguez J; Avery RK; Lard M; Budev M; Gordon SM; Shrestha NK; van Duin D; Oethinger M; Mawhorter SD
Clin Infect Dis; 2009 Sep; 49(5):710-6. PubMed ID: 19635026
[TBL] [Abstract][Full Text] [Related]
18. Outcome of other organs recovered during in situ split-liver procurements.
Ramcharan T; Glessing B; Lake JR; Payne WD; Humar A
Liver Transpl; 2001 Oct; 7(10):853-7. PubMed ID: 11679982
[TBL] [Abstract][Full Text] [Related]
19. The Onset of de novo Hepatocellular Carcinoma after Liver Transplantation can be both of Donor and Recipient origin. A Case Report.
Tamè M; Calvanese C; Cucchetti A; Gruppioni E; Colecchia A; Bazzoli F
J Gastrointestin Liver Dis; 2015 Sep; 24(3):387-9. PubMed ID: 26405713
[TBL] [Abstract][Full Text] [Related]
20. Rapid progression of small cell carcinoma in a renal transplant recipient.
Rannikko A; Krogerus L; Nyberg M; Salmela K; Ruutu M
Int J Urol; 2006 Jun; 13(6):817-9. PubMed ID: 16834670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
